Brett SaladinoDrug discovery and development laboratory adds key resource

 Maryland Heights, MO – Seventh Wave Laboratories, LLC ( announced today that Brett Saladino, DVM, Diplomate ACVP has joined the firm to support their growing portfolio of clients. Dr. Saladino comes with extensive experience in GLP Safety Assessment of both small and large molecule drugs. She also has expertise in leadership, training, team building, collaboration, and process excellence.

Dr. Saladino spent the last fourteen years supporting pharmaceutical research and development. Prior to her work in the pharmaceutical industry, Dr. Saladino served ten years in the United States Army Veterinary Corps, with six years at the Armed Forces Institute of Pathology, first as a resident, then Training Officer, and ultimately Chief, Diagnostic Services Branch. At AFIP she performed diagnostic histopathology, trained pathology residents, developed training materials, and directed several national pathology courses. She also serves on the Board of Directors of the C.L. Davis and S.W. Thompson DVM Foundation.

Dr. Saladino joins Seventh Wave as an anatomic pathologist to support pharmacology and toxicology studies. “I have been impressed with the high quality science and service provided by Seventh Wave for many years. I am thrilled to be joining this highly respected team, and I look forward to helping them continue to grow.”

Joe Flynn, Chief Commercial Officer said “Our clients rely on our pathology expertise to provide scientific continuity throughout their discovery and development experience. Adding to our strong team of pathologists is fundamental to our brand. Brett’s deep experience and knowledge make her a great addition.   We feel very fortunate that we were able to find someone of Brett’s caliber to fulfill this role.”

 About Seventh Wave Laboratories, LLC Company

Seventh Wave is a consulting and contract research organization ( which integrates the disciplines of pharmacology, drug metabolism and pharmacokinetics, toxicology, and pathology. The company provides nonclinical evaluations of drug efficacy, safety, systemic exposure, and metabolism from their laboratories near St. Louis, MO.